Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10
/in Dendritic Cells, HIV/AIDS, International Publications /von 2009-06-15 / J. Infect. Dis. 2009 Jun;199(12):1862-71Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2009-06-10 / J. Virol. 2009 Aug;83(16):8108-21Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2009-06-01 / Oncol. Rep. 2009 Jun;21(6):1585-92Cellular immunotherapy for ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2009-06-01 / Expert Opin Biol Ther 2009 Jun;9(6):677-88Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2009-06-01 / Int. J. Oncol. 2009 Jun;34(6):1701-15[Dendritic cell-based immunotherapy for multiple myeloma — review]
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2009-06-01 / Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 Jun;17(3):821-5Hyperthermia as an immunotherapy strategy for cancer
/in Hyperthermia, International Publications /von 2009-06-01 / Curr Opin Investig Drugs 2009 Jun;10(6):550-8Generation of a dendritic cell-based vaccine in chronic lymphocytic leukaemia using CliniMACS platform for large-scale production
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2009-06-01 / Scand. J. Immunol. 2009 Jun;69(6):529-36
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution